This trial is active, not recruiting.

Condition pneumococcal infection
Treatment serotypes and resistance
Sponsor King Saud University
Start date February 2009
End date October 2009
Trial size 300 participants
Trial identifier NCT00844467, king Saud university


The purpose of this study is to establish retrospectively the incidence rates of invasive pneumococcal disease in children aged less than 5 years. The investigators allocate the El Hasa region for the study because it has higher incidence of sickle cell anemia. The study will include data from 2003 to 2007(before introduction of the vaccine) and then for 2008 and 2009 (after introduction of the vaccine).

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Eligibility Criteria

Male or female participants from 3 months up to 5 years old.

Inclusion Criteria: - Invasive pneumococcal disease - Children under 5 years - Children lived in Elhasa region Exclusion Criteria: - Children above 5 years - No invasive pneumococcal disease

Additional Information

Official title Serotyping of Pneumococci
Description Data will be collected from patents files or records for 5 years before the introduction of the vaccine and for 2 years after the introduction of the vaccine. We assigned 4 doctors in each hospital to carry and supervise the work.
Trial information was received from ClinicalTrials.gov and was last updated in February 2009.
Information provided to ClinicalTrials.gov by King Saud University.